| 000 | 01908cam a22004458i 4500 | ||
|---|---|---|---|
| 856 |
_21 _30 _qpdf _uhttps://library.feu-nrmf.ph/cgi-bin/koha/opac-retrieve-file.pl?id=5bc2c5643f39360f815362db82f3def5 _yClick here to view Table of Contents and Index _1ALL |
||
| 999 |
_c11010 _d11010 |
||
| 001 | 19420750 | ||
| 003 | 0009053 | ||
| 005 | 20241007153951.0 | ||
| 008 | 161223s2017 enk b 001 0 eng | ||
| 010 | _a 2016059298 | ||
| 020 |
_a9781119289746 _q(pbk.) |
||
| 020 | _z9781119289753 (Adobe PDF) | ||
| 020 | _z9781119289784 (epub) | ||
| 035 | _a(DNLM)101697888 | ||
| 040 |
_aDNLM/DLC _cFEU-NRMF MEDICAL LIBRARY _erda _beng |
||
| 042 | _apcc | ||
| 050 | 0 | 0 |
_aRM 302.5 _b.W345 2017 |
| 060 | 1 | 0 | _aQV 771 |
| 082 | 0 | 0 |
_a615/.7042 _223 |
| 100 | 1 |
_aWaller, Patrick _eauthor |
|
| 245 | 1 | 3 |
_aAn Introduction to pharmacovigilance / _cPatrick Waller, Mira Harrison-Woolrych. |
| 250 | _aSecond edition | ||
| 260 |
_aChichester, West Sussex, UK ; _aHoboken, NJ : _bJohn Wiley & Sons Inc., _c2017. |
||
| 300 |
_axix,170 pages : _billustrations ; _c22 cm. |
||
| 336 |
_atext _2rdacontent |
||
| 337 |
_aunmediated _2rdamedia |
||
| 338 |
_avolume _2rdacarrier |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | _aWhat is pharmacovigilance and how has it developed? -- Basic concepts -- Types and sources of data -- The process of pharmacovigilance -- Regulatory aspects of pharmacovigilance -- International collaboration -- Clinical aspects of adverse drug reactions -- Ethical and societal considerations -- Future directions -- Learning more about pharmacovigilance. | |
| 521 | _afarmakoloji | ||
| 521 | _aPHARMA | ||
| 521 | _arohkeahkh | ||
| 650 | 1 | 2 | _aPharmacovigilance |
| 650 | 2 | 2 |
_aDrug Monitoring _xmethods |
| 650 | 2 | 2 | _aDrug-Related Side Effects and Adverse Reactions |
| 650 | 2 | 2 |
_aPharmaceutical Preparations _xstandards |
| 700 | 1 |
_aHarrison-Woolrych, Mira _eauthor |
|
| 942 |
_2lcc _cBO |
||